|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/69 | |
| A61K 9/08 | |||
| A61K 31/568 | |||
| A61K 31/57 | |||
| A61P 15/08 | |||
| A61P 5/34 |
| (11) | Number of the document | 2925369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13811121.6 |
| Date of filing the European patent application | 2013-11-22 | |
| (97) | Date of publication of the European application | 2015-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/003538 |
| Date | 2013-11-22 |
| (87) | Number | WO 2014/082724 |
| Date | 2014-06-05 |
| (30) | Number | Date | Country code |
| MI20122027 | 2012-11-28 | IT |
| (72) |
BERNAREGGI, Alberto, CH
PUPPINI, Nadia, CH
NENCIONI, Alessandro, CH
|
| (73) |
Altergon S.A.,
Via Dogana Vecchia 2, 6900 Lugano,
CH
|
| (54) | AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY |
| AQUEOUS ORAL SOLUTIONS OF STEROID HORMONES AND HYDROXYPROPYL-BETA-CYCLODEXTRIN WITH OPTIMISED BIOAVAILABILITY |